10 Healthcare and Insurance Stocks to Buy as Democrats Take Control
Washington handed healthcare investors a fresh catalyst on November 3. Democrats’ sweep of…
10 Healthcare and Insurance Stocks to Buy as Democrats Take Control
Washington handed healthcare investors a fresh catalyst on November 3. Democrats’ sweep of the House and Senate revived…
5 Healthcare and Insurance Stocks to Buy as Democrats Take Control
We recently published our article 10 Healthcare and Insurance Stocks to Buy as Democrats Take Control. In this…
Johnson & Johnson (JNJ) Flexes Its Oncology Muscle With 16.4% Sales Growth
For cancer patients, progress can mean more time, fewer side effects, and a better chance of recovery. For…
Would You Still Dare to Invest in Revolution Medicines (RVMD)?
For cancer patients, progress can mean more time, fewer side effects, and a better chance of recovery. For…
Merck (MRK) Has an $8.6 Billion Cancer Franchise and a Succession Plan to Prove
For cancer patients, progress can mean more time, fewer side effects, and a better chance of recovery. For…
AbbVie (ABBV) Delivers $17.4 Billion in Revenue
For cancer patients, progress can mean more time, fewer side effects, and a better chance of recovery. For…
Pfizer (PFE) Gets an Oncology Boost as Padcev Sales Surge 55%
For cancer patients, progress can mean more time, fewer side effects, and a better chance of recovery. For…
Guardant Health (GH) Posts 44% Revenue Growth as Liquid Biopsy Gains Ground
For cancer patients, progress can mean more time, fewer side effects, and a better chance of recovery. For…
Natera (NTRA) Gets a Growth Spurt as Cancer Testing Volume Jumps 57%
For cancer patients, progress can mean more time, fewer side effects, and a better chance of recovery. For…
Is it Still a Wise Move to Invest in Cogent Biosciences (COGT)?
For cancer patients, progress can mean more time, fewer side effects, and a better chance of recovery. For…
Bristol Myers (BMY) Brings In $13.1 Billion but the Patent Clock Keeps Ticking
For cancer patients, progress can mean more time, fewer side effects, and a better chance of recovery. For…
Tango Therapeutics (TNGX) Turns Heads With an 82% Cancer Response Rate
For cancer patients, progress can mean more time, fewer side effects, and a better chance of recovery. For…
5 Best Cancer Stocks to Buy Now According to Hedge Funds
5. Pfizer Inc. (NYSE:PFE) Number of Hedge Fund Holders — 83 Oncology Growth Gives the Turnaround Story Fresh…
10 Best Cancer Stocks to Buy Now According to Hedge Funds
For cancer patients, progress means more time, fewer side effects, and a better chance of recovery. For investors,…
Xenon Pharmaceuticals (XENE) is the Top Billionaire Ranking Pick
Biotech investors are searching for the next blockbuster medicine, while pharmaceutical giants are searching for something equally valuable:…
Is it a Good Time to Invest in Tango Therapeutics (TNGX)?
Biotech investors are searching for the next blockbuster medicine, while pharmaceutical giants are searching for something equally valuable:…
Definium Therapeutics (DFTX) Posts Positive Anxiety Trial Results
Biotech investors are searching for the next blockbuster medicine, while pharmaceutical giants are searching for something equally valuable:…
Arcutis (ARQT) Delivers 59% ZORYVE Sales Growth
Biotech investors are searching for the next blockbuster medicine, while pharmaceutical giants are searching for something equally valuable:…